STAT3 and Hepatic fibrosis: These data have been strengthened by the finding that administration of IL-10, a recently recognized inhibitor of autophagy through activation of STAT3 [20, 21], can reverse the beneficial effects of the IL-17A antagonism on experimental liver fibrosis.